James M. Lippman
Known title: DirectorCIK: 0001610739
Associated companies
Transaction History
| CCS | ▲ Buy | Grant | 3,225 | $0 | 5/6/2026 | View on chart |
| CCS | ▼ Sell | Gift | 7,675 | $0 | 2/3/2026 | View on chart |
| CCS | ▲ Buy | Grant | 3,286 | $0 | 5/7/2025 | View on chart |
| CCS | ▲ Buy | Grant | 2,113 | $0 | 5/8/2024 | View on chart |
| CCS | ▼ Sell | Gift | 7,138 | $0 | 11/3/2023 | View on chart |
| CCS | ▲ Buy | Grant | 2,661 | $0 | 5/3/2023 | View on chart |
| CCS | ▲ Buy | Grant | 2,846 | $0 | 5/5/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
CCS Expands DFW, Downgrade Noted, Earnings Date Set
The company announced it will acquire HistoryMaker Homes, tripling its Dallas‑Fort Worth presence. Analysts at Seeking Alpha suggested a downgrade as broader market conditions worsen. CCS also set the date for its third‑quarter 2026 earnings release and conference call. The stock is currently near a support level and has an RSI indicating modest momentum.
CCS Expands DFW, Downgrade Noted, Earnings Date Set. The company announced it will acquire HistoryMaker Homes, tripling its Dallas‑Fort Worth presence. Analysts at Seeking Alpha suggested a downgrade as broader market conditions worsen. CCS also set the date for its third‑quarter 2026 earnings release and conference call. The stock is currently near a support level and has an RSI indicating modest momentum.